Allopurinol and its principal metabolic product, oxipurinol (alloxanthine, oxoallopurinol), inhibit the enzyme, xanthine oxidase, that normally converts hypoxanthine to xanthine, and xanthine to ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA ● CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX ...

Type B Meeting Discussion to Accelerate XRx-026 for Gout to NDA CALGARY, Alberta, March 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ: XRTX | TSXV: XRTX | Fra ...

Mayuresh Joshi of William O'Neil India puts forth a list of 11 stocks, inspired by the India Champions Trophy-winning team, ...

Hyperuricemia (HU) is a metabolic disorder characterized by elevated uric acid (UA) levels in the bloodstream, commonly diagnosed when UA levels ...

广东省医疗援藏首席专家、广东省人民医院李欣教授，上海百趣代谢组学技术研究中心刘志鹏研究员和范艳群研究员为共同通讯作者；广东省人民医院陈轩馥博士后、邹国祥博士及杨智博博士为论文共同第一作者。

In addition to being a neurotransmitter, adenosine is classified as a chemical known as a xanthine. Every cell in the body contains some adenosine contained within DNA and RNA. How Adenosine Impacts ...

Zurampic is approved by the FDA for hyperuricemia associated with uncontrolled gout, in combination with a xanthine oxidase inhibitor (XOI). Duzallo is a combination of lesinurad and allopurinol ...

At present, oral xanthine oxidase inhibitors (“XOIs”) are the preferred therapeutic option used to inhibit the production of uric acid and decrease high uric acid levels in gout patients. Allopurinol ...